Lineage Cell Therapeutics (LCTX) Gross Margin Growth (5y) (2016 - 2026)
Lineage Cell Therapeutics (LCTX) Gross Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,864.00 |
| Dec 31, 2025 | 3,111.00 |
| Sep 30, 2025 | 1,773.00 |
| Jun 30, 2025 | 1,802.00 |
| Mar 31, 2025 | 1,589.00 |
| Dec 31, 2024 | 454.00 |
| Sep 30, 2024 | 1,910.00 |
| Jun 30, 2024 | 1,061.00 |
| Mar 31, 2024 | 54.00 |
| Dec 31, 2023 | -540.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 22.00 |
| Mar 31, 2023 | 1,056.00 |
| Dec 31, 2022 | -533.00 |
| Sep 30, 2022 | -784.00 |
| Jun 30, 2022 | -472.00 |
| Mar 31, 2022 | -336.00 |
| Dec 31, 2021 | -9,807.00 |
| Sep 30, 2021 | -4,339.00 |
| Jun 30, 2021 | -2,441.00 |